ISSN 2398-2942      

Maropitant citrate

icanis
Contributor(s):

Clive Elwood

Vetstream Ltd

Synonym(s): Cerenia®


Introduction

Name

  • Maropitant citrate.

Class of drug

  • Anti-emetic.
  • Neurokinin (NK1) receptor antagonist.

Description

Chemical name

  • (2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate.

Molecular formula

  • C32H40N20C6H807H20

Molecular weight

  • 678.81

Physical properties

  • Peach-colored oval tablets (16, 24, 60 and 160 mg of maropitant as maropitant citrate per tablet).
  • Injectable solution (10 mg maropitant, 63 mg sulphobutylether-beta-cyclodextrin, 3.3 mg meta-cresol and water).

Storage requirements

  • Store at controlled room temperature (20-25°C; 68-77°F) with excursions between 15-30°C (59-86°F).
  • Use vial of injectable solution within 28 days of first vial puncture.

Uses

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Indications

  • Prevention of emesis Vomiting.
  • Prevention of emesis associated with motion sickness.

Administration

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Pharmacokinetics

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Interactions

with other drugs

  • Use with caution with other protein bound drugs. The concomitant use of Cerenia® with other protein bound drugs such as NSAIDs, cardiac, anticonvulsant and behavioral medications has not been evaluated.

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Benchaoui H A, Siedek E M, de la Puente-Redondo V A, Tilt N, Rowan T G & Clemence R G (2007) Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs. Vet Rec 161, 444-447 PubMed.
  • Benchaoui H A, Cox S R, Schneider R P, Boucher J F & Clemence R G (2007) The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor anatagonist, in dogs. J Vet  Pharmacol Ther 30 (4), 336-344 PubMed.
  • de la Puente-Redondo V A, Siedek E M, Benchaoui H A, Tilt N, Rowan T G & Clemence R G (2007) The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe. JSAP 48 (2), 93-98 PubMed.
  • de la Puente-Redondo V A, Tilt N, Rowan T G & Clemence R G (2007) Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. Am  J Vet Res 68 (1), 48-56 PubMed.

Other sources of information

MEMBER BENEFIT

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!

 
 
 
 

To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code